Clinical Laserthermia Systems AB (publ)

OM:CLS BTU B Rapporto sulle azioni

Cap. di mercato: SEK 81.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Clinical Laserthermia Systems Gestione

Gestione criteri di controllo 3/4

Clinical Laserthermia Systems' CEO is Dan Mogren, appointed in Dec 2020, has a tenure of 3.58 years. directly owns 0.075% of the company’s shares, worth SEK61.21K. The average tenure of the management team and the board of directors is 2.5 years and 3.5 years respectively.

Informazioni chiave

Dan Mogren

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO3.6yrs
Proprietà del CEO0.07%
Durata media del management2.5yrs
Durata media del Consiglio di amministrazione3.5yrs

Aggiornamenti recenti sulla gestione

Nessun aggiornamento

Recent updates

Nessun aggiornamento

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Dan Mogren rispetto agli utili di Clinical Laserthermia Systems?
DataCompenso totaleStipendioGuadagni aziendali
Mar 31 2024n/an/a

-SEK 71m

Dec 31 2023n/an/a

-SEK 80m

Sep 30 2023n/an/a

-SEK 63m

Jun 30 2023n/an/a

-SEK 77m

Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022SEK 1mSEK 1m

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensazione vs Mercato: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensazione vs guadagni: Dan's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Dan Mogren (60 yo)

3.6yrs

Mandato

SEK 1,373,158

Compensazione

Mr. Dan Johansson Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Dan Mogren
Chief Executive Officer3.6yrsSEK 1.37m0.075%
SEK 61.2k
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 1.65mNessun dato
Hakan Rosqvist
Interim Chief Financial Officerless than a yearNessun datoNessun dato
Jimmy Johansson
Executive Vice President of Operations1.2yrsNessun dato0.0014%
SEK 1.1k
Cristina Pantaleone
Chief Technical Officer2.5yrsNessun datoNessun dato
Liselotte Nilsson
Vice President of Marketing3.5yrsNessun dato0.0047%
SEK 3.8k
Karin Peterson
Chief Product Officerno dataNessun datoNessun dato

2.5yrs

Durata media

57yo

Età media

Gestione esperta: CLS BTU B's management team is considered experienced (2.5 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Lars-Erik Eriksson
Co-Founder & Director18.5yrsSEK 1.65mNessun dato
Stephan Dymling
Director2.5yrsSEK 75.00k0.0078%
SEK 6.4k
Hans von Celsing
Independent Chairman of the Board11.5yrsSEK 250.00k0.0036%
SEK 2.9k
Gunilla Savring
Independent Director4.5yrsSEK 142.50kNessun dato
Rolf Kiessling
Member of Clinical Advisory Board3.1yrsSEK 80.00kNessun dato
Karl-Göran Tranberg
Member of Clinical Advisory Board3.1yrsSEK 80.00k0.078%
SEK 63.7k
Paolo Raffaelli
Independent Director3.5yrsSEK 62.50k0.00072%
SEK 588.9
Marika Crohns
Independent Director & Member of Clinical Advisory Board4.5yrsSEK 142.50k0.0070%
SEK 5.7k
Sandy Brandmeier
Independent Director3.5yrsNessun dato0.013%
SEK 10.5k

3.5yrs

Durata media

69yo

Età media

Consiglio di amministrazione esperto: CLS BTU B's board of directors are considered experienced (3.5 years average tenure).